Patents by Inventor Hyun J. Yoon
Hyun J. Yoon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230027466Abstract: An implantable medical device (IMD) automatically determines at least a portion of the parameters and, in some instances all of the parameters, of an exposure operating mode based on stored information regarding sensed physiological events or therapy provided over a predetermined period of time. The IMD may configure itself to operate in accordance with the automatically determined parameters of the exposure operating mode in response to detecting a disruptive energy field. Alternatively, the IMD may provide the automatically determined parameters of the exposure operating mode to a physician as suggested or recommended parameters for the exposure operating mode. In other instances, the automatically determined parameters may be compared to parameters received manually via telemetry and, if differences exist or occur, a physician or patient may be notified and/or the manual parameters may be overridden by the automatically determined parameters.Type: ApplicationFiled: September 28, 2022Publication date: January 26, 2023Inventors: Michael L. Ellingson, Hyun J. Yoon
-
Patent number: 11522919Abstract: This disclosure is directed to devices, systems, and techniques for establishing a secure connection between two or more devices. In some examples, a device is configured for wireless communication. The device comprises signal reception circuitry configured to receive communications transmitted according to at least a first communication protocol, communication circuitry configured for wireless communication according to at least a second communication protocol, and processing circuitry electrically coupled to the signal reception circuitry and the communication circuitry. The processing circuitry is configured to receive, via the signal reception circuitry, a first signal according to the first communication protocol. In response to receiving the first signal, the processing circuitry is further configured to transmit, via the communication circuitry, a second signal according to the second communication protocol and establish a secure link according to the second communication protocol.Type: GrantFiled: January 31, 2019Date of Patent: December 6, 2022Assignee: Medtronic, Inc.Inventors: Hyun J Yoon, Bo Zhang, Robert Michael Ecker, Ryan Wyszynski, Joseph C Green, David J. Peichel, Sudar Shields, Nicholas C. Wine, Drew J. Thwaites
-
Patent number: 11478647Abstract: An implantable medical device (IMD) automatically determines at least a portion of the parameters and, in some instances all of the parameters, of an exposure operating mode based on stored information regarding sensed physiological events or therapy provided over a predetermined period of time. The IMD may configure itself to operate in accordance with the automatically determined parameters of the exposure operating mode in response to detecting a disruptive energy field. Alternatively, the IMD may provide the automatically determined parameters of the exposure operating mode to a physician as suggested or recommended parameters for the exposure operating mode. In other instances, the automatically determined parameters may be compared to parameters received manually via telemetry and, if differences exist or occur, a physician or patient may be notified and/or the manual parameters may be overridden by the automatically determined parameters.Type: GrantFiled: November 27, 2019Date of Patent: October 25, 2022Assignee: MEDTRONIC, INC.Inventors: Michael L. Ellingson, Hyun J. Yoon
-
Patent number: 11464985Abstract: Techniques for switching an implantable medical device (IMD) from a first mode to a second mode in relation to signals obtained from internal sensors are described. The internal sensors may include a temperature sensor and a biosensor. In some examples, processing circuitry of the IMD may make a first preliminary determination that the IMD is implanted based on a first signal from the temperature sensor. In response to the first preliminary determination being that the IMD is implanted, the processing circuitry may make a second preliminary determination that the IMD is implanted based on a second signal from the biosensor. The processing circuitry may switch the IMD from a first mode to a second mode based on both the first preliminary determination and the second preliminary determination being that the IMD is implanted.Type: GrantFiled: July 21, 2020Date of Patent: October 11, 2022Assignee: Medtronic, Inc.Inventors: Robert M. Ecker, Matthew P. Hanly, Charles R. Gordon, Gary J. Pauly, Michael B. Terry, Jerry D. Reiland, Hyun J. Yoon, Ryan D. Wyszynski, Jon E. Thissen
-
Patent number: 11400298Abstract: Techniques are disclosed for using a rate of wireless telemetry of an implantable medical device (IMD) to estimate a remaining longevity of a power source of the IMD. For example, the IMD sets a timer indicative of a remaining power capacity of the power source until a recommended replacement time (RRT) threshold. The IMD determines a power consumption of the IMD due to telemetry and updates, based on the power consumption of the IMD due to telemetry, the timer indicative of the remaining power capacity of the power source. The IMD determines, based on expiration of the timer indicative of the remaining power capacity of the power source, that the power source has reached the RRT threshold. In some examples, the IMD may output, to an external device and for display to a user, an indication that the power source has reached the RRT threshold.Type: GrantFiled: May 4, 2020Date of Patent: August 2, 2022Assignee: Medtronic, Inc.Inventors: Matthew J. Hoffman, Matthew P. Hanly, Evan S. Johnson, Gary J. Pauly, Jerry D. Reiland, Melani G. Sullivan, Ryan D. Wyszynski, Hyun J. Yoon
-
Publication number: 20220168578Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.Type: ApplicationFiled: February 18, 2022Publication date: June 2, 2022Inventors: Hyun J. Yoon, Wade M. Demmer, Matthew J. Hoffman, Robert A. Betzold, Jonathan D. Edmonson, Michael L. Ellingson, Mark K. Erickson, Ben W. Herberg, Juliana E. Pronovici, James D. Reinke, Todd J. Sheldon, Paul R. Solheim
-
Publication number: 20220160250Abstract: This disclosure is directed to techniques for detecting and mitigating inaccurate sensing in a medical system. In some examples, one or more sensors of the medical system may include at least one electrode configured to sense an impedance of a portion of a patient's body proximate to the electrode and processing circuitry of the medical system may detect an inaccuracy in the data corresponding to the one or more patient physiological parameters based upon data including at least the sensed impedance of the portion of the patient body; correct at least a portion of the inaccuracy in the data corresponding to the one or more patient physiological parameters; and generate, for display on a display device, output data indicating the inaccuracy in the data corresponding to the one or more patient physiological parameters.Type: ApplicationFiled: November 23, 2020Publication date: May 26, 2022Inventors: David A. Anderson, James H. Borowick, Hyun J. Yoon, Jon E. Thissen, Shantanu Sarkar, Ashley L. Galarneau, Jason C. Lee
-
Publication number: 20220133999Abstract: A system for monitoring a patient includes one or more processors and a sensor device implemented in circuitry. The system is configured to measure, using the sensor device, an impedance of tissue of the patient and determine, using one or more processors, a physiological parameter comprising at least one of a heart rate, cardiac output, vascular tone, perfusion level, fluid status, respiration effort, or respiration rate of the patient based on the impedance of the tissue of the patient. The system is configured to facilitate therapy, using the one or more processors, based on the determined physiological parameter.Type: ApplicationFiled: October 30, 2020Publication date: May 5, 2022Inventors: Jason C. Lee, Hyun J. Yoon, Jon E. Thissen, Ashley L. Galarneau, Randal C. Schulhauser
-
Publication number: 20220072316Abstract: A medical device is configured to generate an acceleration signal and a temperature signal. The device is configured to determine an activity metric from the acceleration signal that is representative of patient physical activity. In response to determining that the activity metric is equal to or greater than a previously determined activity metric, the device is configured to adjust a target cardiac pacing rate based at least on a temperature change determined from the temperature signal. The device may include a pulse generator for generating cardiac pacing pulses based on the target cardiac pacing rate.Type: ApplicationFiled: August 17, 2021Publication date: March 10, 2022Inventors: Hyun J. YOON, Vincent P. GANION, Yanina GRINBERG, Saul E. GREENHUT, Todd J. SHELDON, Paul R. Solheim, Eric R. WILLIAMS
-
Patent number: 11253707Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.Type: GrantFiled: October 14, 2019Date of Patent: February 22, 2022Assignee: Medtronic, Inc.Inventors: Hyun J. Yoon, Wade M. Demmer, Matthew J. Hoffman, Robert A. Betzold, Jonathan D. Edmonson, Michael L. Ellingson, Mark K. Erickson, Ben W. Herberg, Juliana E. Pronovici, James D. Reinke, Todd J. Sheldon, Paul R. Solheim
-
Publication number: 20220031184Abstract: This disclosure is directed to devices, systems, and techniques for dynamically adjusting a bio impedance measurement range. An example device includes a plurality of electrodes. The device also includes sensing circuitry configured to sense a bio impedance and processing circuitry. The processing circuitry is configured to apply an excitation signal to the sensing circuitry and, based on the application of the excitation signal, determine a sensed bio impedance value within a bio impedance measurement range. The processing circuitry is also configured to determine whether the sensed bio impedance value is within a predetermined portion of the bio impedance measurement range for a predetermined period of time and based on the sensed bio impedance value being within the predetermined portion of the bio impedance measurement range for the predetermined period of time, adjust the excitation signal.Type: ApplicationFiled: July 20, 2021Publication date: February 3, 2022Inventors: Hyun J. Yoon, Jon E. Thissen, Jerry D. Reiland, Ashley L. Galarneau
-
Publication number: 20210370076Abstract: Techniques for switching an implantable medical device (IMD) from a first mode to a second mode in relation to signals obtained from internal sensors are described. The internal sensors may include a temperature sensor and a biosensor. In some examples, processing circuitry of the IMD may make a first preliminary determination that the IMD is implanted based on a first signal from the temperature sensor. In response to the first preliminary determination being that the IMD is implanted, the processing circuitry may make a second preliminary determination that the IMD is implanted based on a second signal from the biosensor. The processing circuitry may switch the IMD from a first mode to a second mode based on both the first preliminary determination and the second preliminary determination being that the IMD is implanted.Type: ApplicationFiled: July 21, 2020Publication date: December 2, 2021Inventors: Robert M. Ecker, Matthew P. Hanly, Charles R. Gordon, Gary J. Pauly, Michael B. Terry, Jerry D. Reiland, Hyun J. Yoon, Ryan D. Wyszynski, Jon E. Thissen
-
Publication number: 20210339028Abstract: Techniques are disclosed for using a rate of wireless telemetry of an implantable medical device (IMD) to estimate a remaining longevity of a power source of the IMD. For example, the IMD sets a timer indicative of a remaining power capacity of the power source until a recommended replacement time (RRT) threshold. The IMD determines a power consumption of the IMD due to telemetry and updates, based on the power consumption of the IMD due to telemetry, the timer indicative of the remaining power capacity of the power source. The IMD determines, based on expiration of the timer indicative of the remaining power capacity of the power source, that the power source has reached the RRT threshold. In some examples, the IMD may output, to an external device and for display to a user, an indication that the power source has reached the RRT threshold.Type: ApplicationFiled: May 4, 2020Publication date: November 4, 2021Inventors: Matthew J. Hoffman, Matthew P. Hanly, Evan S. Johnson, Gary J. Pauly, Jerry D. Reiland, Melani G. Sullivan, Ryan D. Wyszynski, Hyun J. Yoon
-
Publication number: 20210308465Abstract: A medical device includes a motion sensor configured to sense a motion signal. The medical device includes a control circuit configured to determine at least one ventricular event metric from the motion signal sensed over multiple of atrial cycles, determine that the ventricular event metric meets atrioventricular block criteria and generate an output in response to determining the atrioventricular block.Type: ApplicationFiled: April 2, 2021Publication date: October 7, 2021Inventors: Michelle M. GALARNEAU, Vincent P. GANION, Saul E. GREENHUT, Yanina GRINBERG, Todd J. SHELDON, Paul R. SOLHEIM, Hyun J. YOON
-
Publication number: 20210236828Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.Type: ApplicationFiled: April 19, 2021Publication date: August 5, 2021Inventors: Hyun J. Yoon, Wade M. Demmer, Matthew J. Hoffman, Robert A. Betzold, Jonathan D. Edmonson, Michael L. Ellingson, Ben W. Herberg, Juliana E. Pronovici, James D. Reinke, Todd J. Sheldon, Paul R. Solheim
-
Patent number: 10981010Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.Type: GrantFiled: May 13, 2019Date of Patent: April 20, 2021Assignee: Medtronic, Inc.Inventors: Hyun J. Yoon, Wade M. Demmer, Matthew J. Hoffman, Robert A. Betzold, Jonathan D. Edmonson, Michael L. Ellingson, Ben W. Herberg, Juliana E. Pronovici, James D. Reinke, Todd J. Sheldon, Paul R. Solheim
-
Publication number: 20200252436Abstract: This disclosure is directed to devices, systems, and techniques for establishing a secure connection between two or more devices. In some examples, a device is configured for wireless communication. The device comprises signal reception circuitry configured to receive communications transmitted according to at least a first communication protocol, communication circuitry configured for wireless communication according to at least a second communication protocol, and processing circuitry electrically coupled to the signal reception circuitry and the communication circuitry. The processing circuitry is configured to receive, via the signal reception circuitry, a first signal according to the first communication protocol. In response to receiving the first signal, the processing circuitry is further configured to transmit, via the communication circuitry, a second signal according to the second communication protocol and establish a secure link according to the second communication protocol.Type: ApplicationFiled: January 31, 2019Publication date: August 6, 2020Inventors: Hyun J. Yoon, Bo Zhang, Robert Michael Ecker, Ryan Wyszynski, Joseph C. Green, David J. Peichel, Sudar Shields, Nicholas C. Wine, Drew J. Thwaites
-
Publication number: 20200101298Abstract: An implantable medical device (IMD) automatically determines at least a portion of the parameters and, in some instances all of the parameters, of an exposure operating mode based on stored information regarding sensed physiological events or therapy provided over a predetermined period of time. The IMD may configure itself to operate in accordance with the automatically determined parameters of the exposure operating mode in response to detecting a disruptive energy field. Alternatively, the IMD may provide the automatically determined parameters of the exposure operating mode to a physician as suggested or recommended parameters for the exposure operating mode. In other instances, the automatically determined parameters may be compared to parameters received manually via telemetry and, if differences exist or occur, a physician or patient may be notified and/or the manual parameters may be overridden by the automatically determined parameters.Type: ApplicationFiled: November 27, 2019Publication date: April 2, 2020Inventors: Michael L. ELLINGSON, Hyun J. YOON
-
Publication number: 20200038665Abstract: Implantable medical systems enter an exposure mode of operation, either manually via a down linked programming instruction or by automatic detection by the implantable system of exposure to a magnetic disturbance. A controller then determines the appropriate exposure mode by considering various pieces of information including the device type including whether the device has defibrillation capability, pre-exposure mode of therapy including which chambers have been paced, and pre-exposure cardiac activity that is either intrinsic or paced rates. Additional considerations may include determining whether a sensed rate during the exposure mode is physiologic or artificially produced by the magnetic disturbance. When the sensed rate is physiologic, then the controller uses the sensed rate to trigger pacing and otherwise uses asynchronous pacing at a fixed rate.Type: ApplicationFiled: October 14, 2019Publication date: February 6, 2020Inventors: Hyun J. YOON, Wade M. DEMMER, Matthew J. HOFFMAN, Robert A. BETZOLD, Jonathan D. EDMONSON, Michael L. ELLINGSON, Mark K. ERICKSON, Ben W. HERBERG, Juliana E. PRONOVICI, James D. REINKE, Todd J. SHELDON, Paul R. SOLHEIM
-
Patent number: 10493286Abstract: An implantable medical device (IMD) automatically determines at least a portion of the parameters and, in some instances all of the parameters, of an exposure operating mode based on stored information regarding sensed physiological events or therapy provided over a predetermined period of time. The IMD may configure itself to operate in accordance with the automatically determined parameters of the exposure operating mode in response to detecting a disruptive energy field. Alternatively, the IMD may provide the automatically determined parameters of the exposure operating mode to a physician as suggested or recommended parameters for the exposure operating mode. In other instances, the automatically determined parameters may be compared to parameters received manually via telemetry and, if differences exist or occur, a physician or patient may be notified and/or the manual parameters may be overridden by the automatically determined parameters.Type: GrantFiled: October 19, 2015Date of Patent: December 3, 2019Assignee: Medtronic, Inc.Inventors: Michael L. Ellingson, Hyun J. Yoon